# Peculiar Cat with Many Lives: PUMA in Viral Infections

**Authors:** Zbigniew Wyżewski, Justyna Stępkowska, Pola Pruchniak, Adrianna Niedzielska, Karolina Paulina Gregorczyk-Zboroch, Matylda Barbara Mielcarska

PMC · DOI: 10.3390/cells15030278 · Cells · 2026-02-01

## TL;DR

This paper explores how the protein PUMA influences viral infections and how viruses manipulate it to survive, with implications for treatment.

## Contribution

The paper systematically reviews PUMA's role in various viral infections and the strategies viruses use to modulate it.

## Key findings

- PUMA can both promote and inhibit viral infections depending on the context.
- Viruses use multiple strategies to suppress or manipulate PUMA activity.
- Understanding PUMA's role may lead to new therapeutic approaches for viral diseases.

## Abstract

Apoptosis is a natural mechanism that shapes morphogenesis and helps maintain tissue homeostasis in healthy organisms. It is also extensively studied in the context of pathologies such as cancer and viral infections. The course of the latter strictly depends on host cell viability; therefore, regulators of apoptosis may play essential roles in distinct viral infections as well as virus-dependent diseases. The p53-upregulated modulator of apoptosis (PUMA), a pro-apoptotic member of the B-cell lymphoma 2 (Bcl-2) family, directly disrupts mitochondrial integrity, thereby promoting the intrinsic apoptotic pathway. PUMA-mediated cell death act as a double-edged sword that may either facilitate viral infection and its consequences or counteract them, depending on the infectious agent and the complex context of pathogen–host interactions. Accordingly, various viruses have evolved strategies to modulate host cell viability to their advantage by targeting PUMA—either by suppressing transcription of the PUMA gene, binding and inactivating the PUMA protein, or, conversely, inducing its production. In this work, we describe the role of PUMA in infections caused by distinct viruses and in associated diseases, viral strategies for modulating PUMA-related signaling pathways, and potential therapeutic implications.

## Linked entities

- **Genes:** BBC3 (BCL2 binding component 3) [NCBI Gene 27113]
- **Proteins:** BBC3 (BCL2 binding component 3)

## Full-text entities

- **Genes:** BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, BBC3 (BCL2 binding component 3) [NCBI Gene 27113] {aka JFY-1, JFY1, PUMA}
- **Diseases:** infection (MESH:D007239), cancer (MESH:D009369), Viral Infections (MESH:D014777)
- **Species:** Felis catus (cat, species) [taxon 9685]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12896748/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12896748/full.md

## References

211 references — full list in the complete paper: https://tomesphere.com/paper/PMC12896748/full.md

---
Source: https://tomesphere.com/paper/PMC12896748